tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Synthomer Director Invests in Company Shares

Story Highlights
Synthomer Director Invests in Company Shares

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Synthomer ( (GB:SYNT) ) just unveiled an announcement.

Synthomer PLC announced that Uwe Halder, a Non-Executive Director, has purchased 25,000 ordinary shares of the company at a price of £0.637 per share, totaling £15,925. This transaction, conducted on the London Stock Exchange, reflects a significant investment by a key member of the company’s board, potentially indicating confidence in the company’s future performance and stability.

The most recent analyst rating on (GB:SYNT) stock is a Buy with a £275.00 price target. To see the full list of analyst forecasts on Synthomer stock, see the GB:SYNT Stock Forecast page.

Spark’s Take on GB:SYNT Stock

According to Spark, TipRanks’ AI Analyst, GB:SYNT is a Neutral.

Synthomer’s overall stock score is primarily impacted by its weak financial performance and bearish technical indicators. While recent corporate events show management confidence, the company’s financial struggles and negative valuation metrics weigh heavily on its prospects.

To see Spark’s full report on GB:SYNT stock, click here.

More about Synthomer

Synthomer PLC operates in the chemical industry, specializing in the production of polymers and related products. The company focuses on providing innovative solutions across various sectors including coatings, construction, textiles, and healthcare.

Average Trading Volume: 705,848

Technical Sentiment Signal: Sell

Current Market Cap: £101.1M

See more data about SYNT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1